Vitamin D3

Category: Health | Vida Vertical

Summary

Vitamin D3 (cholecalciferol) is unusual among micronutrients because the skin can synthesise it under UV-B radiation. At Central European latitudes, production varies markedly by season and individual circumstances. This article explains cutaneous synthesis and activation, established roles in calcium and bone metabolism, the clinical consequences of deficiency and evidence-based approaches to food, sunlight and supplementation. It also assesses UV-treated mushrooms and other controlled-production options without treating algae or aquaponics as automatically reliable sources.

1. Introduction: A Vitamin with Hormone-Like Actions

Vitamin D is often called the “sunshine vitamin”, but its active metabolite acts as a steroid hormone. The body can synthesise vitamin D3 when sufficient UV-B reaches the skin, while dietary sources and supplements become important when endogenous production is inadequate.

Seasonal mood and energy changes cannot be explained mainly by vitamin D alone. Daylight exposure, circadian rhythms, activity and mental health also matter. Low vitamin D status is associated with several outcomes, but association does not prove that supplementation prevents them in people without deficiency.

2. Biochemistry of Vitamin D Synthesis: From Sunlight to Active Hormone

2.1 Cutaneous Synthesis

UV-B radiation, mainly around 290–315 nm, converts 7-dehydrocholesterol in the epidermis to previtamin D3, which thermally isomerises to cholecalciferol.

No fixed exposure time guarantees adequate synthesis. It varies with latitude, season, time of day, cloud, clothing, skin pigmentation, age and exposed area, and must be balanced against skin-cancer risk:

• Latitude: At higher latitudes the solar angle reduces effective UV-B, especially in winter.
• Season: In Central Europe, cutaneous synthesis is greatly reduced or absent for parts of autumn and winter.
• Skin pigmentation: More melanin generally requires longer exposure for comparable synthesis, although individual variation is substantial.
• Sun protection: Sunscreen reduces UV-B under controlled conditions, but real-world use does not justify intentional sunburn or abandoning skin-cancer prevention.
• Age: Cutaneous synthesis capacity generally declines with age.

2.2 Hepatic and Renal Activation

Cholecalciferol undergoes two principal hydroxylation steps:

1. Liver: It is converted to 25-hydroxyvitamin D [25(OH)D, calcidiol], the major circulating form used to assess status.
2. Kidney and other tissues: 25(OH)D is converted to 1,25-dihydroxyvitamin D (calcitriol), the active form; renal production is tightly regulated by calcium, phosphate, parathyroid hormone and FGF23.

Calcitriol binds the vitamin D receptor and regulates gene expression in target tissues.

2.3 Dietary Sources

Food contributes vitamin D, although natural concentrations are limited and variable. Values depend on species, feed, season, processing and fortification:

Meeting needs from unfortified foods alone can be difficult, but feasibility depends on diet, fortification and endogenous synthesis.

3. Physiological Functions: Bone Health and Beyond

3.1 Calcium and Phosphate Metabolism

Calcitriol increases intestinal calcium and phosphate absorption and interacts with parathyroid hormone and the kidneys to maintain mineral balance. Severe deficiency impairs mineralisation and can cause rickets in children or osteomalacia in adults.

3.2 Immune Function

Vitamin D receptors and metabolising enzymes occur in immune cells, and vitamin D influences innate and adaptive immune signalling. Adequacy supports normal physiology, but supplementation has not been shown to prevent all infections or autoimmune diseases.

3.3 Endocrine and Metabolic Associations

Vitamin D signalling interacts with many tissues, including pancreatic cells and reproductive organs. Observational associations with testosterone, insulin sensitivity and mood do not establish that supplements improve these outcomes in people without deficiency.

3.4 Cell Proliferation and Differentiation

Calcitriol affects proliferation and differentiation in experimental systems. Observational links between 25(OH)D and colorectal-cancer risk are being studied, but routine high-dose supplementation is not established as cancer prevention.

4. Vitamin D Status in Central Europe

Low vitamin D status is common in some groups, particularly during winter, but prevalence depends on the threshold, population and measurement method:

• Geography and season: Winter UV-B at Central European latitudes is often insufficient for meaningful skin synthesis.
• Lifestyle: Limited outdoor time, covering clothing and institutional living reduce exposure; sun protection remains important for preventing skin damage.
• Diet: Few unfortified foods contain substantial vitamin D.

Serum 25(OH)D is the standard status marker. Thresholds differ among authorities; concentrations below about 12 ng/mL (30 nmol/L) indicate deficiency risk, while values around 20 ng/mL (50 nmol/L) are sufficient for most people according to several public-health bodies. A universal “optimal” range of 30–70 ng/mL is not established.

5. Clinical Manifestations of Vitamin D Deficiency

Deficiency can produce skeletal and muscular manifestations; many nonspecific symptoms have other causes:

Musculoskeletal:

• Rickets in children and osteomalacia in adults
• Greater fracture risk in susceptible older adults
• Muscle weakness, particularly with severe deficiency
• Dental problems may reflect many factors and are not a specific sign of vitamin D deficiency

Neurological and psychological:

• Sleep disturbance is not a specific diagnostic feature
• Irritability and mood changes are nonspecific
• Depression and seasonal affective disorder have multifactorial causes
• Cognitive symptoms require broader clinical assessment

Immune-related:

• Severe deficiency may coexist with greater infection risk, but causality varies by outcome
• Associations with autoimmune disease do not prove prevention through supplementation
• Poor wound healing is nonspecific and has many causes

Cardiovascular:

• Low status is observationally associated with cardiovascular risk
• Trials have not established vitamin D as a general blood-pressure treatment

6. Evidence-Based Intake and Supplementation

6.1 Sunlight and Food

Brief regular outdoor exposure can support synthesis in suitable seasons, but no universal minute-based prescription is safe or sufficient. Avoid sunburn and follow skin-cancer guidance. Body stores may contribute during winter, while food and supplements can fill gaps.

6.2 Supplementation

When endogenous synthesis is absent, the DGE reference intake is 20 µg (800 IU) daily for adults. Treatment of confirmed deficiency may require a clinician-directed regimen. Routine intake of 2,000–5,000 IU for everyone is not evidence-based and can exceed public-health recommendations.

Important considerations:

• Testing is useful for people at risk or when deficiency is suspected, but universal screening before ordinary low-dose supplementation is not generally required.
• Vitamin K2 is not routinely required with vitamin D. People taking vitamin-K antagonists should not start K supplements without medical advice; proposed MK-7 doses are not universal recommendations.
• Excess vitamin D can cause hypercalcaemia, kidney injury and soft-tissue calcification, usually through excessive supplements rather than sunlight.

6.3 Situations Requiring Medical Supervision

People with hypercalcaemia, significant kidney disease, granulomatous disease such as sarcoidosis, hyperparathyroidism or certain malignancies should use vitamin D only with medical guidance.

7. Relevance to Vida Vertical: Vitamin D from Controlled Production

Controlled food production offers a few relevant options, particularly UV-treated mushrooms, but standard hydroponic plants do not produce nutritionally meaningful vitamin D:

1. UV-Induced Vitamin D Enrichment of Edible Mushrooms Mushrooms are fungi, not plants. Their ergosterol can be converted by UV light into vitamin D2 before or after harvest. Controlled exposure can substantially increase content, but the dose varies and requires labelling, process validation and food-safety controls.

2. Microalgae in Photobioreactors Some algae contain vitamin D compounds or precursors, but content, form and human bioavailability vary greatly. Chlorella and spirulina should not be treated as dependable vitamin D sources without product-specific analysis and evidence.

3. Fish in Aquaculture and Aquaponics Fish vitamin D content depends on species, feed and husbandry. Salmon and trout may contribute, but freshwater aquaponics does not reproduce oily marine fish values automatically, and every product requires compositional data.

4. UV-B in Indoor Farms UV treatments can influence phytochemicals in leafy vegetables and vitamin D2 in fungi, but ordinary leafy plants do not thereby become useful vitamin D foods. UV also presents worker, crop and material-safety risks and requires controlled engineering.

5. Year-Round Production Indoor systems can produce UV-treated mushrooms year-round. Algae and fish may contribute only when species, feed, process and measured composition support the claim; season-independent production does not itself guarantee vitamin D density.

8. Conclusion

Vitamin D acts through an endocrine system central to calcium and bone metabolism, with additional biological roles still under study. Seasonal low status is common in risk groups at Central European latitudes, but prevalence and clinical significance depend on thresholds and individual circumstances.

Prevention combines safe outdoor exposure, suitable foods or fortification and supplementation when needed. UV-treated mushrooms can provide vitamin D2 from controlled production; algae and aquaponic fish should be assessed product by product rather than presented as guaranteed solutions.

Understanding natural and controlled processes supports informed choices—from safe sunlight exposure to validated UV treatment of edible fungi.

Note: This article provides general information and does not replace medical assessment. Testing and clinician-supervised treatment are advisable for suspected deficiency or relevant illness, particularly kidney disease, hypercalcaemia or sarcoidosis. Avoid unsupervised high-dose regimens.

References:

• Holick, M. F. (2007). Vitamin D deficiency. New England Journal of Medicine, 357(3), 266–281.
• Zhou, A., Selvanayagam, J. B. & Hyppönen, E. (2021). Non-Linear Mendelian Randomization Analyses Support a Role for Vitamin D Deficiency in Cardiovascular Disease Risk. European Heart Journal, 43(1), 89–99.
• German Cancer Research Center (DKFZ). (2022). Vitamin D enrichment of foods—potential for cancer prevention. Press release.
• German Nutrition Society (DGE): D-A-CH Reference Values for Nutrient Intake. Vitamin D. www.dge.de
• Bouillon, R., Marcocci, C., Carmeliet, G., et al. (2019). Skeletal and Extraskeletal Actions of Vitamin D: Current Evidence and Outstanding Questions. Endocrine Reviews, 40(4), 1109–1151.
• Pilz, S., März, W., Cashman, K. D., et al. (2018). Rationale and Plan for Vitamin D Food Fortification: A Review and Guidance Paper. Frontiers in Endocrinology, 9, 373.

Author: Uwe | Vida Vertical – Health